In an epigenome-wide association study of depression, the researchers tied DNA methylation to disease symptoms and suggested a role for axon guidance disruption.
This could mean that clinical boundaries between psychiatric disorders might not reflect their underlying biology, Brainstorm Consortium researchers said.
While a randomized-controlled trial is underway, Genomind hopes data from a new case-control study will convince insurers its PGx test can reduce healthcare utilization costs.
Researchers described diet-related patterns of gut microbial diversity, microbiome ties to psychiatric disease, and more.
The company presented new data on the PGx test this week and expressed confidence that they can secure broader payor coverage for it.
Genetic tests may help psychiatrists choose which drugs to start their patients on, the Wall Street Journal reports.
An international team of researchers combined data from seven cohorts to uncover 30 novel depression-linked loci, including ones that overlap with schizophrenia.
In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.
The researchers used UK Biobank data to identify loci linked to depression and identify gene sets involved in excitatory neurotransmission and mechanosensory behavior.
The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.